Davis Polk & Wardwell

News About Davis Polk & Wardwell

Davis Polk hires Hogan Lovells M&A chief ahead of merger

Longtime Hogan dealmaker Bill Curtin joins in Washington DC just days before his former firm combines with Cadwalader Wickersham & Taft

26 Jun 2026

Trio of firms guide GSK’s $10.6bn US cancer drug maker buy

Davis Polk and Slaughter and May advise GSK as Ropes & Gray counsels target Nuvalent

10 Jun 2026

Davis Polk launches Los Angeles office with longtime Skadden partner

New York firm’s first office in Southern California to be led by former Skadden litigator Jason Russell

1 May 2026

Davis Polk, Latham in for Klarna’s $1.4bn IPO as US listings rebound

Davis Polk guides Swedish fintech company’s much-anticipated listing on NYSE as Latham counsels underwriters

11 Sep 2025

Trio of top M&A firms guide CoreWeave’s $9bn Core Scientific AI acquisition

David Polk and Kirkland & Ellis advise CoreWeave as Wachtell Lipton Rosen & Katz acts for Core Scientific in deal to meet AI power needs

8 Jul 2025

Wachtell, Davis Polk lead $6.7bn merger of troubled drugmakers Mallinckrodt and Endo

Hogan Lovells, Paul Weiss and Ireland’s Arthur Cox and A&L Goodbody also act in tie-up of drugmakers with shared history of opioid crisis lawsuits

14 Mar 2025

Cravath, Davis Polk advise on Johnson & Johnson’s $14.6bn Intra-Cellular acquisition

Cravath advises longtime client J&J as it boosts key neurological drugs division

14 Jan 2025

Skadden, Goodwin, Davis Polk act as Novo closes $16.5bn Catalent deal

Jones Day, Linklaters and Arnold & Porter also called in for the largest healthcare buyout of 2024

20 Dec 2024

Davis Polk recruits Sidley partner duo to launch London restructuring practice

Arrival of Mark Knight and Jifree Cader follows partner raids on A&O Shearman and Paul Hastings earlier in 2024

11 Nov 2024

Skadden, Davis Polk called in as Emerson completes acquisition of AspenTech

Emerson calls on longtime adviser Davis Polk as Skadden reps Aspen

6 Nov 2024